微信小陈
微信小章
产品简介
购买须知
| 产品名称： | 3E1 |
|---|---|
| 商品货号： | TS212882 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Animals were immunized with purified HSV-2 nucleocapsids. Spleen cells were fused with P3-NSI/1-Ag4-1 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against nucleocapsid (p40) of herpes simplex virus type 2 (HSV-2) |
| Cellular Products： | immunoglobulin; monoclonal antibody; against nucleocapsid (p40) of herpes simplex virus type 2 (HSV-2) |
| Comments： | Animals were immunized with purified HSV-2 nucleocapsids. Spleen cells were fused with P3-NSI/1-Ag4-1 myeloma cells. The antibody precipitates p40 and p45 from HSV-2 but not from HSV-1. |
| Complete Growth Medium： | Culture Medium: RPMI 1640 medium with 1 mM sodium pyruvate, 85%; fetal bovine serum, 15%. |
| Subculturing： | Medium Renewal: 2 to 3 times per week Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 1 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Cryopreservation： | Modified Dulbeccos medium (10% FBS), 95%; DMSO, 5% |
| Isotype： | IgG1 |
| Name of Depositor： | The United States of America |
| U.S. Patent Number： | |
| References： | Zweig M, et al. Production of monoclonal antibodies against nucleocapsid proteins of Herpes simplex Virus types 1 and 2. J. Virol. 32: 676-678, 1979. PubMed: 91687 Zweig M, et al. Test methods employing monoclonal antibodies against Herpes simplex virus types 1 and 2 nucleocapsids proteins. US Patent 4,430,437 dated Feb 7 1984 |